MetaADEDB 2.0 @ LMMD
Angular cheilitis
(UMLS:C0221237)
UMLS ID:
C0221237
MeSH ID:
N/A
Synonym(s)
1.
Angular cheilitis
2.
Angular Cheilitis
3.
Angular cheilosis
4.
Angular stomatitis
5.
Cheilosis
6.
Commissural cheilitis
7.
Inflammation of corners of the mouth
8.
Inflammation of oral commisures
9.
Intertrigo labialis
10.
PERLECHE
11.
Perleche
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1MetronidazoleFAERS: 7US FAERS
2IsotretinoinFAERS: 6US FAERS
3AfatinibFAERS: 4US FAERS
4AllopurinolFAERS: 4US FAERS
5MetforminFAERS: 4US FAERS
6SunitinibFAERS: 4US FAERS
7Fingolimod HydrochlorideFAERS: 3US FAERS
8rucaparibFAERS: 3US FAERS
9trametinibFAERS: 3US FAERS
10MetforminFAERS: 2US FAERS
11pirfenidoneFAERS: 2US FAERS
124-AminopyridineFAERS: 1US FAERS
134-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
14AzithromycinFAERS: 1US FAERS
15Bevespi AerosphereFAERS: 1US FAERS
16CanagliflozinFAERS: 1US FAERS
17CapecitabineFAERS: 1US FAERS
18CarbamazepineFAERS: 1US FAERS
19CinacalcetFAERS: 1US FAERS
20Dimethyl FumarateFAERS: 1US FAERS
21Duloxetine HydrochlorideFAERS: 1US FAERS
22EsomeprazoleFAERS: 1US FAERS
23EverolimusFAERS: 1US FAERS
24Ibandronic AcidFAERS: 1US FAERS
25Mycophenolic AcidFAERS: 1US FAERS
26NevirapineFAERS: 1US FAERS
27OmeprazoleFAERS: 1US FAERS
28SorafenibFAERS: 1US FAERS
29TadenanFAERS: 1US FAERS
30TopiramateFAERS: 1US FAERS
31VemurafenibFAERS: 1US FAERS
32etonogestrelFAERS: 1US FAERS
33regorafenibFAERS: 1US FAERS
34temsirolimusFAERS: 1US FAERS
35tiotropium-olodaterolFAERS: 1US FAERS
36tofacitinibFAERS: 1US FAERS
37FluconazoleCanada Vigilance: 1Canada Vigilance
38GabapentinSIDER
39MirtazapineCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.